Catalyst Wire Dossier Catalyst Wire Dossier

Semaglutide ER Injectable Suspension

semaglutide · Novo Nordisk
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Semaglutide ER Injectable Suspension, covering 2024-05-22 to 2024-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects [Phase 1]

See pricing